Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.59
Dec. 19, 2025 16:00:02- Change 0.0012 (0.20516%)
- Volume 7,373,869
- Today's Open 0.594
- Previous Close 0.5849
- Today's High 0.625
- Today's Low 0.5555
- 52 Week High 4.3
- 52 Week Low 0.281